Literature DB >> 6384370

The requirement for proteinase activity for human lymphocyte-mediated natural cytotoxicity (NK): evidence that the proteinase is serine dependent and has aromatic amino acid specificity of cleavage.

D Hudig, D Redelman, L L Minning.   

Abstract

We used reagents specific for serine-dependent proteinases to verify that a proteinase of this class is necessary for natural cytotoxicity (NK). NK was inhibited by phenylmethylsulfonylfluoride (PMSF), by diisopropylfluorophosphate (DFP), and by the plasma antiproteinase alpha-1-antichymotrypsin (alpha-1-X), all of which are specific for serine-dependent proteinases. Substrate specificity was then determined on the basis of the specificity of the plasma and fungal anti-proteinases and synthetic alternate substrates that affected NK. alpha-1-X, which inhibits only serine proteinases with aromatic amino acid specificity, blocked NK. Chymostatin, but not other fungal inhibitors, also blocked NK activity. Furthermore, the only synthetic substrates that effectively reduced NK were those derived from aromatic amino acids. The ester derivatives of these substrates inhibited NK better than the amides. NK inhibition with these alternate substrates was also stereospecific, with the L forms twofold more active than the D forms. These reagents did not block initial lymphocyte-target cell binding. Therefore we propose that the "NK-proteinase" is involved in either the initiation of cytolysis, perhaps as part of stimulus and secretion of cytolytic molecules, or in the cascade of events that may lead to the formation of final lytic substance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6384370

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp.

Authors:  J A Trapani
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

2.  Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias.

Authors:  S H Lim; C Worman; A Jewell; C Tsakona; F J Giles; A Goldstone
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Casein expression in cytotoxic T lymphocytes.

Authors:  M J Grusby; S C Mitchell; N Nabavi; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.

Authors:  A Bajpai; B S Kwon; Z Brahmi
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

5.  Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain.

Authors:  R Uellner; M J Zvelebil; J Hopkins; J Jones; L K MacDougall; B P Morgan; E Podack; M D Waterfield; G M Griffiths
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

Review 6.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

7.  Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.

Authors:  B Cowan; O Baron; J Crack; C Coulber; G J Wilson; M Rabinovitch
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates.

Authors:  F Dallegri; G Frumento; A Ballestrero; R Goretti; A Torresin; F Patrone
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

9.  Heterogeneity of murine adherent interleukin-2-activated killer cells. Differential effect of prostaglandin E2 and forskolin.

Authors:  D Vaillier; R Daculsi; N Gualde
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

10.  Granules of cytolytic T-lymphocytes contain two serine esterases.

Authors:  D Masson; M Nabholz; C Estrade; J Tschopp
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.